Webcast: Fit-for-purpose: The Evolving Role of Liver Biopsies in MASH Clinical Trials and Patient Management
Fit-for-purpose: The Evolving Role of Liver Biopsies in MASH Clinical Trials and Patient management Post Drug-approval Date: 30 May 204 About the Webcast The recent FDA approval of Rezdiffra™ (resmetirom) for the treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH) has marked a significant milestone in the management of this complex liver disease. In light of this …